您的位置: 首页 > 农业专利 > 详情页

Arni's composition of factor 12 (Hageman factor) (F12), California B, plasma (Fletcher factor) 1 (klkb1) and quiingeno 1 (kng1) and its application
专利权人:
ALNYLAM PHARMACEUTICALS; INC.
发明人:
MAIER MARTIN,HINKLE GREGORY,AKINC AKIN,LIU JINGXUAN,BUTLER JAMES
申请号:
UY36671
公开号:
UY36671A
申请日:
2016.05.06
申请国别(地区):
UY
年份:
2016
代理人:
摘要:
The current invention is related to Armenian agents, for example, Armenian agents with double Hebrews, who are fighting against calicrimna gene B, plasmatica (Fletcher factor) I (klkbi),Gene of factor 12 (Hageman factor (F 12),Or quinine I (kng1)And methods for inhibiting the expression of klkb1 gene, F12 gene and / or kng1 gene by using these RNI mediators, as well as methods for handling genetic angioplasty (HAE) and 10 untranstore related to contact activation pathway.La presente invenciôn se relaciona con agentes de ARM, por ejemplo, agentes de ARM de doble hebra, contra el gen de Calicremna B, Plasmática (Factor de Fletcher) I (KLKBI), el gen del Factor XII (Factor de Hageman (F 12), o el gen del Quininogeno I (KNG1), y métodos para usar dichos agentes de ARNi para inhibir La expresión de un gen KLKB1, un gen F12, y/o un gen KNG1, y métodos para tratar sujetos que tienen un angioedema hereditarlo (HAE) y10 untrastorno asociado con la via do activación por contacto.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充